Form 8-K Vera Therapeutics, Inc. For: Jan 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Wall Street ends higher as tech rebounds before Nvidia results
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
Vera Therapeutics (VERA) Terminates ATM Offering
January 29, 2024 6:28 AM ESTEffective January 29, 2024, Vera Therapeutics Inc. (NASDAQ: VERA) suspended and terminated the prospectus (the ATM Prospectus) related to the sale of its Class A common stock, $0.001 par value per share (the Common Stock) in an at-the-market offering pursuant to the terms of the Sales Agreement, dated June 3, 2022, by and between the Company and Cowen and Company, LLC (the Sales Agreement). As a result, the Company will not make any sales of its Common... More
